The chemical substance with the name "L-Leucine, L-phenylalanyl-L-leucyl-L-arginylglycyl-L-arginyl-L-alanyl-L-tyrosylglycyl-" and CAS number 139143-28-5 is a peptide composed of multiple amino acids, specifically including L-leucine, L-phenylalanine, L-arginine, glycine, L-alanine, and L-tyrosine. This compound is characterized by its complex structure, which contributes to its potential biological activity. Peptides like this one often exhibit properties such as being soluble in water and having the ability to interact with various biological receptors, which may influence physiological processes. The presence of multiple amino acids suggests that it may play a role in protein synthesis or act as a signaling molecule in biological systems. Additionally, the specific arrangement of amino acids can affect its stability, reactivity, and overall function. Such peptides are of interest in fields like biochemistry, pharmacology, and nutrition, where they may be studied for their therapeutic potential or role in metabolic processes.

L-Leucine, L-phenylalanyl-L-leucyl-L-arginylglycyl-L-arginyl-L-alanyl-L-tyrosylglycyl-

139143-28-5: The chemical substance with the name "L-Leucine, L-phenylalanyl-L-leucyl-L-arginylglycyl-L-arginyl-L-alanyl-L-tyrosylglycyl-" and CAS number 139143-28-5 is a peptide composed of multiple amino acids, specifically including L-leucine, L-phenylalanine, L-arginine, glycine, L-alanine, and L-tyrosine. This compound is characterized by its complex structure, which contributes to its potential biological activity. Peptides like this one often exhibit properties such as being soluble in water and having the ability to interact with various biological receptors, which may influence physiological processes. The presence of multiple amino acids suggests that it may play a role in protein synthesis or act as a signaling molecule in biological systems. Additionally, the specific arrangement of amino acids can affect its stability, reactivity, and overall function. Such peptides are of interest in fields like biochemistry, pharmacology, and nutrition, where they may be studied for their therapeutic potential or role in metabolic processes.

HLA-B*0801-bindingEBV peptide, derived from the Epstein-Barr virus (EBV) epitope FLRGRAYGL, interacts with the HLA-B*0801 molecule. This peptide is presented to CD8+ T cells via HLA-B*0801, thereby activating a specific immune response.

CAS 139143-28-5

L-Leucine, L-phenylalanyl-L-leucyl-L-arginylglycyl-L-arginyl-L-alanyl-L-tyrosylglycyl-

HLA-B*0801-binding EBV peptide

Ref: TM-TP2835